Published in Int Clin Psychopharmacol on September 01, 2003
The pharmacological management of migraine, part 2: preventative therapy. P T (2008) 0.85
Headache in pregnancy: a nuisance or a new sense? Obstet Gynecol Int (2012) 0.76
Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res (2005) 1.66
Remission in schizophrenia: critical and systematic review. Harv Rev Psychiatry (2012) 1.51
Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther (2010) 1.11
Hypomania induced by adjunctive lamotrigine. Am J Psychiatry (2003) 1.01
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol (2004) 1.01
Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment? J Psychopharmacol (2012) 0.92
Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. J Clin Psychiatry (2002) 0.87
Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia. Int Clin Psychopharmacol (2005) 0.84
Seizures, coma, and coagulopathy following olanzapine overdose. Can J Psychiatry (2005) 0.84
Weight loss during prolonged branched-chain amino acid treatment for tardive dyskinesia in a patient with schizophrenia. Aust N Z J Psychiatry (2006) 0.83
Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use. Can J Psychiatry (2004) 0.81
Diabetes insipidus secondary to combination atypical antipsychotic and lithium use in a bipolar disorder patient: a case report. Prim Care Companion CNS Disord (2011) 0.80
Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine. J Clin Psychopharmacol (2011) 0.79
Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Can J Clin Pharmacol (2007) 0.79
Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. Clin Schizophr Relat Psychoses (2015) 0.78
Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia. Can J Psychiatry (2002) 0.78
Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia. Can J Psychiatry (2004) 0.78
Alternative pharmacotherapy for trichotillomania: a report of successful bupropion use. J Clin Psychiatry (2004) 0.77
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can J Clin Pharmacol (2006) 0.76
Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment. J Clin Psychopharmacol (2003) 0.76
Long-term lamotrigine adjunctive to antipsychotic monotherapy in schizophrenia: further evidence. Can J Psychiatry (2004) 0.75
Fungal dermatitis with olanzapine in schizophrenia. Can J Psychiatry (2003) 0.75
Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy (2004) 0.75
Using the rating scale for psychotic symptoms to characterize delusions expressed in a schizophrenia patient with "Internet psychosis". Can J Psychiatry (2002) 0.75
First- and second-generation antipsychotics. Can J Psychiatry (2010) 0.75
Donepezil-associated mania in two patients who were using donepezil without a prescription. J Clin Psychopharmacol (2014) 0.75
Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine. Can J Psychiatry (2003) 0.75
Possible association of syndrome of inappropriate secretion of antidiuretic hormone with St John's wort use. J Clin Psychopharmacol (2014) 0.75
Clozapine for first-episode schizophrenia. Am J Psychiatry (2002) 0.75